Eleison Pharmaceuticals   Report issue

For profit Phase 2 Phase 3
Founded: Princeton NJ United States (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2008
NCT00442598
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Eleison Pharmaceuticals LLC. | Gynecologic Oncology Research & Development, LLC

Active Ingredients

Drugs in Phase 3 Trials (2)

fluorouracil (efudex) (1 trial)

glufosfamide (3 trials)

Drugs in Phase 2 Trials (1)

cisplatin (platinol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 3)

Carcinoma, Ovarian Epithelial (Phase 2)

Osteosarcoma (Phase 2)

Ovarian Neoplasms (Phase 2)

Recurrence (Phase 2)

Sarcoma (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 3